AzTrials
AzTrials

Acetabular FractureNCT04724811

Weight-bearing of Surgically Treated Acetabular Fractures.

A study testing Open reduction and internal fixation (ORIF) in people with Acetabular Fracture, run by Hospital District of Helsinki and Uusimaa at 1 site in Finland.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to determine whether patients with operatively treated acetabular fractures benefit from early weight-bearing as tolerated. The study compares two groups ( n = 25 each), which are randomised into either weight-bearing as tolerated or touch-down weight-bearing for 6-8 weeks postoperatively. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Acetabular Fracture
What is being tested?
Open reduction and internal fixation (ORIF)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteFinland
Study dates
May 2024to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Unilateral dislocated acetabulum fracture (displacement of over 2mm in preoperative CT scan)
  • The osteosynthesis is performed during 21 days after initial trauma
  • The patient is willing to participate in the follow-up

Who cannot join

  • Unwillingness to participate in randomisation
  • Bilateral fracture
  • Letournel \& Judet type Both column or Posterior column and wall fractures
  • Any other injury that prevents the patient from partial weight bearing
  • Open fracture of the acetabulum
  • Pathologic fracture (fragility fractures are not an exclusion criteria)
Show all 12Show fewer
  • Prior functional disability in the pelvis or lower extremity
  • Non-Compliance due to dementia or other mental disability
  • Prior daily pain medication due to hip-pain
  • Unwillingness to accept one of the two mobilisation protocols
  • Prior hip replacement on injured side
  • BMI > 40

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Kristian Seppänen, MD contact

094711

kristian.seppanen@hus.fi

Jan Lindahl, MD, PhD contact

094711

jan.lindahl@hus.fi

Finland1 site
  • Helsinki University Hospital

    Helsinki, Uusimaa, 00029 HUS

Other trials in Finland

About this study

Official title: Weight-bearing of Surgically Treated Acetabular Fractures. A Randomised Controlled Trial

The purpose of this study is to determine whether patients with operatively treated acetabular fractures benefit from early weight-bearing as tolerated. The study compares two groups ( n = 25 each), which are randomised into either weight-bearing as tolerated or touch-down weight-bearing for 6-8 weeks postoperatively.

Both study groups are stratified according to

Read more
  • Type of fracture (anterior approach vs anterior + additional posterior approach)
  • Dislocated dome vs non-dislocated/ non existing separate dome fragment

Patients, who are eligible to participate in the trial but choose not to participate in randomisation are asked to enrol in a prospective cohort follow-up cohort. This is to examine a potential participation bias in the RCT groups. These patients will not be counted into the target amount of 50 RCT patients.

Read the detailed description

For the past 20 years, the established treatment of dislocated acetabular fractures has been surgical reduction and stable osteosynthesis. Good long-term results have been reported in these patients. At present, the mobilisation of these patients after surgery is generally restricted for several weeks ranging from 6-12 weeks touch-down- or non-weight-bearing with no uniform protocol. However there is no scientific evidence for limiting post operative weight-bearing. Accordingly the need of studies on weight-bearing surrounding periarticular fractures has been advocated.

Acetabular fractures in the elderly population are becoming more common and pose significant challenges for treatment including postoperative rehabilitation. Our aim is to investigate if patients benefit of a more liberal weight-bearing regime postoperatively. The primary outcome is measured at 1 year, secondary outcomes are followed up to 10 years postoperatively

Being tested
Open reduction and internal fixation (ORIF)
Keywords
Acetabulum, Periarticular fracture, Weight-bearing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Open reduction and internal fixation (ORIF)Procedure or surgery

    Approaches used:

    • Intrapelvic approach +/- iliac window
    • Kocher-Langenbeck approach
Study groups in NCT04724811
Study groupRoleWhat they receive
Weight-bearing as toleratedExperimentalPatients are instructed to mobilise the hip and weight-bear as tolerated
Receives: Procedure: Open reduction and internal fixation (ORIF)
Touch-down weight-bearingActive comparatorPatients are instructed to mobilise the hip. Touch-down weight-bearing for 6-8 weeks
Receives: Procedure: Open reduction and internal fixation (ORIF)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. mHHS

    Modified Harris Hip Score, Scale 0-100, higher scores mean better outcome

    Measured: 1 year

  2. NRS

    Pain during gate, Numerical Rating Scale, Scale 0-10 0=no pain, 10=worst pain

    Measured: 1 year

Secondary outcomes (4)
  1. mHHS

    Modified Harris Hip Score, Scale 0-100, higher scores mean better outcome

    Measured: 0 weeks, 6 weeks, 12 weeks, 6 months, 2 years, 5 years, 10 years

  2. NRS

    Pain at rest and during gate (2 scores), Numerical Rating Scale, Scale 0-10 0=no pain, 10=worst pain

    Measured: 0 weeks, 6 weeks, 12 weeks, 6 months, 1 year, 2 years, 5 years, 10 years

  3. WOMAC

    Western Ontario and McMaster Universities Osteoarthritis Index, Scale 0-96, higher scores mean better outcome

    Measured: 0 weeks, 1 year, 2 years, 5 years, 10 years

  4. RAND36

    Patient reported quality of life, Scale 0-100, higher scores mean better outcome

    Measured: 0 weeks, 1 Year, 2 years, 5 years, 10 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2021
  2. Study startMay 2024 (estimated)
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective randomised non-inferiority study
Masking
Double blind
Who is masked
Care provider, Investigator
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04724811
Sponsor's protocol ID
HUS/234/2020
Status last verified
Mar 2024
First submitted
22 Jan 2021
Last updated
6 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Open reduction and internal fixation (ORIF) in people with Acetabular Fracture, run by Hospital District of Helsinki and Uusimaa at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kristian Seppänen, MD (094711, kristian.seppanen@hus.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

mHHS (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2024; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in